Your generous support today will enable basic science research to get back on track as rapidly as possible post COVID-19.
It’s a global priority to flatten the curve and stop the spread of COVID-19.
Yet, cancer is not going away. With one in two Canadians diagnosed with cancer and one in four
dying from the disease, it is critical that our work to find a cure continues.
The cancer community is especially vulnerable to COVID-19. ICRF supervising physicians and
their teams have the added pressure to ensure their patients have the best care possible while
navigating a threatening health crisis.
ICRF Montreal presently funds research and clinical fellowships in the following cancer areas :
DR. LORENZO FERRI
Director, Upper G.I. Cancer Program, McGill University
Professor of Surgery & Oncology, McGill University
Head, Division of Thoracic and Upper Gastrointestinal Surgery, McGill University Health Centre
Esophageal, Lung and Stomach Cancers
DR. WALTER GOTLIEB
Chair ICRF Scientific Advisory Board
Chief, Department of Obstetrics & Gynecology and Division of Gynecologic Oncology, Jewish General Hospital
Professor of Ob-Gyn and Oncology, McGill University
Endometrial, Cervical and Ovarian Cancers
DR. MARC ISLER
Chef Département de Chirugie CIUSS de l’Est de Montréal
Bone cancer and soft tissue sarcomas
DR. NIR LONDON
Senior Scientist, Dept.of Organic Chemistry, The Weizmann Institute of Science
Melanoma
DR. Rotem Rubinstein
Senior Scientist, Dept.of Organic Chemistry, The Weizmann Institute of Science
Melanoma